We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -0.14% | 35.55 | 35.60 | 36.05 | 36.50 | 35.55 | 36.45 | 350,596 | 16:15:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.32 | 106.9M |
TIDMFUM
RNS Number : 9773P
Futura Medical PLC
23 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES -------------------------------------------------------------------------------------- 1. Identity of the issuer or Futura Medical plc the underlying issuer of existing shares to which voting rights are attached: ------------------------------------------------------ ------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ü ------------------------------------------------------- ----------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------- ----------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------- ----------------------------- An event changing the breakdown of voting rights ------------------------------------------------------- ----------------------------- Other (please specify): ----------------------------------------------------- ----------------------------- 3. Full name of person(s) Octopus Investments Nominees subject to the Limited notification obligation: ------------------------------------------------------ ------------------------------ 4. Full name of shareholder(s) n/a (if different from 3.): ------------------------------------------------------ ------------------------------ 5. Date of the transaction 22/11/2016 and date on which the threshold is crossed or reached: ------------------------------------------------------ ------------------------------ 6. Date on which issuer 23/11/2016 notified: ------------------------------------------------------ ------------------------------ 7. Threshold(s) that is/are crossed or reached: 5-8% ------------------------------------------------------ ------------------------------ 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------- ------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights ------------- ---------------- ---------------- -------------- ------------------------ ------------------------- Direct Direct Indirect Direct Indirect ------------- ------------ ------------ -------------- ---------- ------------ ------------ ----------- GB00B0KWHQ09 4440640 4440640 9619079 9619079 8.01% ---------------- ---------------- -------------- ---------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument Period may be acquired if the instrument is exercised/ converted. ----------------- -------------- -------------------------------- -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights instrument period refers to --------------- -------------- -------------- ---------------- -------------------------- ----------------------- Nominal Delta --------------- -------------- -------------- ---------------- -------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------- ----------------------------------------------------------------- 9619079 8.01% --------------------------------------------------- ----------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ----------------------------------------------------------------------- n/a Proxy Voting: ----------------------------------------------------------------------- 10. Name of the proxy holder: n/a ------------------------------------------------------- -------------- 11. Number of voting rights proxy n/a holder will cease to hold: ------------------------------------------------------- -------------- 12. Date on which proxy holder will n/a cease to hold voting rights: ------------------------------------------------------- -------------- 13. Additional information: ------------------------------------------------------- -------------- 14. Contact name: Niki Read ------------------------------------------------------- -------------- 15. Contact telephone number: 0207 776 7969 ------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLPGGCGGUPQGAW
(END) Dow Jones Newswires
November 23, 2016 10:30 ET (15:30 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions